| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1038 |
| Trial ID | ChiCTR-OIC-17011272 |
| Disease | Multiple Myeloma |
| Altered gene | CD19|BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD19 CAR-T cells |
| Recruitment status | Recruiting |
| Title | An open single center single arm clinical study of through infusion of anti-BCMA CAR-T and anti-CD19 CAR-T therapy for relapsed and refractory multiply myeloma |
| Year | 2017 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||